Newborn Screening Services for in support of Naval Hospital Jacksonville, Florida (NH Jacksonville), Naval Hospital Guantanamo Bay, Cuba (USNH GTMO), Naval Medical Center Camp Lejeune, NC (NMCCL) and Naval Medical Center Portsmouth, Virginia (NMCP)
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Defense Health Agency (DHA), under the Department of Defense, is seeking Newborn Screening Services for military beneficiaries at Naval Hospital Jacksonville, FL; Naval Hospital Guantanamo Bay, Cuba; Naval Medical Center Camp Lejeune, NC; and Naval Medical Center Portsmouth, VA. This is a Combined Synopsis/Solicitation (RFQ) for three separate Firm Fixed-Price contracts, awarded on a sole-source basis. Offers are due by March 26, 2026, at 2:00 PM EST.
Scope of Work
This opportunity requires non-personal services to support the Newborn Screening program, ensuring early detection of congenital and metabolic disorders. Services include:
- Provision of collection kits.
- Laboratory analysis of dried blood spot samples.
- Timely electronic reporting of results, including immediate notification for abnormal findings.
- Clinical consultation for follow-up care.
- Training and technical assistance for hospital staff on specimen collection.
- Testing for all conditions mandated by the DHHS Recommended Uniform Screening Panel (RUSP). Services must be performed off-site in CLIA-certified, state-licensed laboratories. Estimated annual birth volumes are: Jacksonville (600), Guantanamo Bay (15), Camp Lejeune (1560), and Portsmouth (2400).
Contract Details & Timeline
- Contract Type: Firm Fixed-Price (three separate contracts).
- NAICS Code: 621511 (Medical Laboratories), with a $41.5M business size standard.
- Set-Aside: This acquisition is not set-aside for small business concerns.
- Period of Performance: A Base Period from May 1, 2026, to April 30, 2027, with up to four one-year option periods extending through April 30, 2031, and a partial Option Period 5 (May 1, 2031 – October 31, 2031) for some locations.
- Justification: Sole source acquisition, citing "Only one responsible source."
Submission & Evaluation
Offerors must submit proposals electronically in two separate volumes: Volume I - Administrative and Volume II - Price.
- Volume I requires SAM registration under NAICS 621511 and a 5% Small Business Subcontracting Plan.
- Volume II requires pricing using the provided Attachment III Excel worksheet, along with price lists or redacted invoices for reasonableness determination. The Government intends to award without discussions, evaluating non-price and price factors equally. Offers must pass all elements of Volume I and present a reasonable price in Volume II.
Key Dates & Contacts
- Questions Deadline: March 20, 2026, 2:00 PM EST.
- Offer Submission Deadline: March 26, 2026, 2:00 PM EST.
- Primary Contact: Brittany Belsches, brittany.n.belsches.civ@health.mil, 301-619-9116.
- Secondary Contact: Mary Shifflett, mary.e.shifflett2.civ@health.mil, 301-610-6160.